Modeling cognitive endophenotypes of schizophrenia in mice

Trends in Neurosciences

Volumn 32, Issue 6, 2009, Pages 347-358

  Kellendonk, Christoph ^a   Simpson, Eleanor H ^a   Kandel, Eric R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE 2 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; LOW DENSITY LIPOPROTEIN RECEPTOR; METHIONINE; NEU DIFFERENTIATION FACTOR; PROLINE DEHYDROGENASE; VALINE;

CHROMOSOME 22Q; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; COGNITIVE DEFECT; DOPAMINE RELEASE; GENE EXPRESSION; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; NEGATIVE SYNDROME; NONHUMAN; PHENOTYPE; POSITIVE SYNDROME; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SELECTIVE ATTENTION; SIGNAL TRANSDUCTION; SPATIAL MEMORY; STATE DEPENDENT LEARNING; WORKING MEMORY;

ANIMALS; COGNITION; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GENE DOSAGE; HUMANS; MICE; MICE, TRANSGENIC; MODELS, GENETIC; PHENOTYPE; POLYMORPHISM, GENETIC; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 66249116695     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2009.02.003     Document Type: Review

References (124)

1. Burmeister M., et al. Psychiatric genetics: progress amid controversy. Nat. Rev. Genet. 9 (2008) 527-540
2. Allen N.C., et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 40 (2008) 827-834
3. Walsh T., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320 (2008) 539-543
4. Stefansson H., et al. Large recurrent microdeletions associated with schizophrenia. Nature 455 (2008) 232-236
5. Consortium T.I.S. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 (2008) 237-241
6. Xu B., et al. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat. Genet. 40 (2008) 880-885
7. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160 (2003) 636-645
8. Brown M.S., and Goldstein J.L. Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man. Science 185 (1974) 61-63
9. Walters J.T., and Owen M.J. Endophenotypes in psychiatric genetics. Mol. Psychiatry 12 (2007) 886-890
10. Kraepelin E. Dementia Praecox and Paraphrenia (1919), Livingstone
11. Malhotra A.K., et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry 159 (2002) 652-654
12. Goldman-Rakic P.S. Working memory dysfunction in schizophrenia. J. Neuropsychiatry Clin. Neurosci. 6 (1994) 348-357
13. Liddle P.F., and Morris D.L. Schizophrenic syndromes and frontal lobe performance. Br. J. Psychiatry 158 (1991) 340-345
14. Nuechterlein K.H., et al. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 72 (2004) 29-39
15. Fuster J.M. Animal Neuropsysiology. In: Fuster J.M. (Ed). The prefrontal cortex: Anatomy, physiology and neuropsychology of the frontal lobe. 3rd edn (1997), Lippincott-Raven 66-102
16. Birrell J.M., and Brown V.J. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J. Neurosci. 20 (2000) 4320-4324
17. Markowitsch H.J., and Pritzel M. Comparative analysis of prefrontal learning functions in rats, cats, and monkeys. Psychol. Bull. 84 (1977) 817-837
18. 2 receptors in the striatum causes persistent deficits in conditional associative learning. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 16027-16032
19. Bissonette G.B., et al. Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J. Neurosci. 28 (2008) 11124-11130
20. Brigman J.L., and Rothblat L.A. Stimulus specific deficit on visual reversal learning after lesions of medial prefrontal cortex in the mouse. Behav. Brain Res. 187 (2008) 405-410
21. Kellendonk C., et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49 (2006) 603-615
22. Touzani K., et al. Consolidation of learning strategies during spatial working memory task requires protein synthesis in the prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5632-5637
23. Goodship J., et al. A population study of chromosome 22q11 deletions in infancy. Arch. Dis. Child. 79 (1998) 348-351
24. Kobrynski L.J., and Sullivan K.E. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11. 2 deletion syndromes. Lancet 370 (2007) 1443-1452
25. Ryan A.K., et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J. Med. Genet. 34 (1997) 798-804
26. Botto L.D., et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112 (2003) 101-107
27. McDonald-McGinn D.M., et al. The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. Genet. Test. 1 (1997) 99-108
28. Niklasson L., et al. Neuropsychiatric disorders in the 22q11 deletion syndrome. Genet. Med. 3 (2001) 79-84
29. Bassett A.S., et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am. J. Med. Genet. A. 138 (2005) 307-313
30. Murphy K.C., et al. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 56 (1999) 940-945
31. Pulver A.E., et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J. Nerv. Ment. Dis. 182 (1994) 476-478
32. Karayiorgou M., and Gogos J.A. The molecular genetics of the 22q11-associated schizophrenia. Brain Res. Mol. Brain Res. 132 (2004) 95-104
33. Paylor R., and Lindsay E. Mouse models of 22q11 deletion syndrome. Biol. Psychiatry 59 (2006) 1172-1179
34. Lindsay E.A., et al. Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature 401 (1999) 379-383
35. Lindsay E.A., et al. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410 (2001) 97-101
36. Merscher S., et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104 (2001) 619-629
37. Jerome L.A., and Papaioannou V.E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 27 (2001) 286-291
38. Paylor R., et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7729-7734
39. Long J.M., et al. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 7 (2006) 247-257
40. Stark K.L., et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40 (2008) 751-760
41. Paterlini M., et al. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat. Neurosci. 8 (2005) 1586-1594
42. St Clair D., et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336 (1990) 13-16
43. Blackwood D.H., et al. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am. J. Hum. Genet. 69 (2001) 428-433
44. Porteous D.J., and Millar J.K. Disrupted in schizophrenia 1: building brains and memories. Trends Mol. Med. 12 (2006) 255-261
45. Cannon T.D., et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch. Gen. Psychiatry 62 (2005) 1205-1213
46. Hodgkinson C.A., et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am. J. Hum. Genet. 75 (2004) 862-872
47. Kamiya A., et al. Recruitment of PCM1 to the centrosome by the cooperative action of DISC1 and BBS4: a candidate for psychiatric illnesses. Arch. Gen. Psychiatry 65 (2008) 996-1006
48. Millar J.K., et al. Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem. Biophys. Res. Commun. 311 (2003) 1019-1025
49. Millar J.K., et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310 (2005) 1187-1191
50. Miyoshi K., et al. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol. Psychiatry 8 (2003) 685-694
51. Morris J.A., et al. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum. Mol. Genet. 12 (2003) 1591-1608
52. Ozeki Y., et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 289-294
53. Sawamura N., et al. Nuclear DISC1 regulates CRE-mediated gene transcription and sleep homeostasis in the fruit fly. Mol. Psychiatry 13 (2008) 1138-1148
54. Kamiya A., et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol. 7 (2005) 1167-1178
55. Duan X., et al. Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 130 (2007) 1146-1158
56. Austin C.P., et al. Expression of disrupted-in-schizophrenia-1, a schizophrenia-associated gene, is prominent in the mouse hippocampus throughout brain development. Neuroscience 124 (2004) 3-10
57. Hikida T., et al. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc. Natl. Acad. Sci. U. S. A 104 (2007) 14501-14506
58. Pletnikov, M.V., et al. (2008) Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 13, 173-186, 115
59. Li W., et al. Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 18280-18285
60. Shen S., et al. Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J. Neurosci. 28 (2008) 10893-10904
61. Schurov I.L., et al. Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol. Psychiatry 9 (2004) 1100-1110
62. Clapcote S.J., et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54 (2007) 387-402
63. Koike H., et al. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3693-3697
64. Kvajo M., et al. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 7076-7081
65. Ma L., et al. Cloning and characterization of Disc1, the mouse ortholog of DISC1 (Disrupted-in-Schizophrenia 1). Genomics 80 (2002) 662-672
66. Ishizuka K., et al. Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Mol. Psychiatry 12 (2007) 897-899
67. Chen J., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 75 (2004) 807-821
68. Tunbridge E.M., et al. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol. Psychiatry 60 (2008) 141-151
69. Munafo M.R., et al. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol. Psychiatry 10 (2005) 765-770
70. Egan M.F., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 6917-6922
71. Bruder G.E., et al. Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol. Psychiatry 58 (2005) 901-907
72. Heinz A., and Smolka M.N. The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Rev. Neurosci. 17 (2006) 359-367
73. Slifstein M., et al. COMT genotype predicts cortical-limbic D1 receptor availability measured with [(11)C]NNC112 and PET. Mol Psychiatry 13 (2008) 821-827
74. 1 receptors and working memory in schizophrenia. J. Neurosci. 22 (2002) 3708-3719
75. Okubo Y., et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385 (1997) 634-636
76. 1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl.) 174 (2004) 3-16
77. Papaleo F., et al. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J. Neurosci. 28 (2008) 8709-8723
78. Badner J.A., and Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatry 7 (2002) 405-411
79. Lewis C.M., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet. 73 (2003) 34-48
80. Stefansson H., et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71 (2002) 877-892
81. Harrison P.J., and Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 60 (2006) 132-140
82. Hall J., et al. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat. Neurosci. 9 (2006) 1477-1478
83. Nicodemus K.K., et al. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol. Psychiatry 11 (2006) 1062-1065
84. Duffy L., et al. Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1. Behav. Neurosci. 122 (2008) 748-759
85. Gerlai R., et al. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav. Brain Res. 109 (2000) 219-227
86. Golub M.S., et al. Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behav. Brain Res. 153 (2004) 159-170
87. O'Tuathaigh C.M., et al. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience 147 (2007) 18-27
88. Chen Y.J., et al. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J. Neurosci 28 (2008) 6872-6883
89. Baumeister A.A., and Francis J.L. Historical development of the dopamine hypothesis of schizophrenia. J. Hist. Neurosci. 11 (2002) 265-277
90. Seeman P., et al. Brain receptors for antipsychotic drugs and dopamine: direct binding assays. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 4376-4380
91. Creese I., et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192 (1976) 481-483
92. Laruelle M. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q. J. Nucl. Med. 42 (1998) 211-221
93. Abi-Dargham A., et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8104-8109
94. Seeman P., and Kapur S. Schizophrenia: more dopamine, more D2 receptors. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7673-7675
95. Frankle W.G. Neuroreceptor imaging studies in schizophrenia. Harv. Rev. Psychiatry 15 (2007) 212-232
96. Lawford B.R., et al. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia. Schizophr. Res 73 (2005) 31-37
97. Hanninen K., et al. Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia. Neurosci. Lett. 407 (2006) 195-198
98. Hoenicka J., et al. C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients. Acta Psychiatr. Scand 114 (2006) 435-438
99. Monakhov M., et al. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophr. Res. 100 (2008) 302-307
100. Mayford M., et al. Control of memory formation through regulated expression of a CaMKII transgene. Science 274 (1996) 1678-1683
101. 2 receptors impairs operant motivation and interval timing. J. Neurosci. 27 (2007) 7731-7739
102. Caspi A., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry 57 (2005) 1117-1127
103. Caspi A., and Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev. Neurosci. 7 (2006) 583-590
104. Smith S.E., et al. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 27 (2007) 10695-10702
105. Karayiorgou M., et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7612-7616
106. Mednick S.A., et al. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry 45 (1988) 189-192
107. Murray R.M., et al. Cannabis, the mind and society: the hash realities. Nat. Rev. Neurosci. 8 (2007) 885-895
108. O'Connell P., et al. Developmental insanity or dementia praecox: was the wrong concept adopted?. Schizophr. Res. 23 (1997) 97-106
109. Thompson P.M., et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11650-11655
110. Davis K.L., et al. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry 148 (1991) 1474-1486
111. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148 (1991) 1301-1308
112. Patil S.T., et al. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat. Med. 13 (2007) 1102-1107
113. Lewis D.A., et al. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6 (2005) 312-324
114. Shenton M.E., et al. A review of MRI findings in schizophrenia. Schizophr. Res. 49 (2001) 1-52
115. Selemon L.D., et al. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J. Comp. Neurol. 392 (1998) 402-412
116. Black J.E., et al. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am. J. Psychiatry 161 (2004) 742-744
117. Glantz L.A., and Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch. Gen. Psychiatry 54 (1997) 943-952
118. Glantz L.A., and Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57 (2000) 65-73
119. Weinberger D.R., and Berman K.F. Prefrontal function in schizophrenia: confounds and controversies. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351 (1996) 1495-1503
120. Gogos J.A., et al. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat. Genet. 21 (1999) 434-439
121. Mukai J., et al. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat. Genet. 36 (2004) 725-731
122. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr. Bull. 32 (2006) 200-202
123. Brown A.S., and Susser E.S. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr. Bull. 34 (2008) 1054-1063
124. Rapoport J.L., et al. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 56 (1999) 649-654